Dishi Medical
Microscopically-assisted robots for high-precision ophthalmic retinal surgeries
About Dishi Medical
Dishi Medical, also known as Dessight Biomedical, is a medical device manufacturer founded in Hangzhou, China, in 2021. The company specializes in developing surgical medical systems for ophthalmic conditions.
The core of its offering consists of microscopically assisted robots designed for retinal surgeries. These systems aim to overcome the physiological limitations of human hand movements, providing high precision, flexibility, and real-time operational response for ultra-high-level fundoplication procedures. The technology is also applicable to other microsurgery fields such as lymphatic, plastic, and neurosurgery, helping to reduce surgeon fatigue and enhance procedural accuracy.
The company operates on a B2B model, manufacturing and supplying these advanced robotic systems to healthcare institutions. Since its inception, Dishi Medical has progressed to a Series A stage, securing significant funding to advance its technology. The company has completed multiple funding rounds, including a Series A round in June 2025 that raised nearly 100 million CNY, led by investors such as Panlin Capital and Jinhe Capital. Its investor base also includes notable firms like Infinity Group, Fortune Capital, and Hillhouse Capital.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2021
- Headquarters
- Hangzhou, China
- Open positions
- None listed
- Dealroom signal
- 21.3/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Ophthalmology, Surgery, Surgical Equipment, Hard Tech, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
- Links
- Website
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Jan 2026 | — | — | Pan-Lin Asset Management · Fortune Venture | ↗ |
| SERIES A✓Equity / VC | Jun 2025 | $14M | $55M | Hangzhou Capital · Sunland fund · Pan-Lin Asset Management | ↗ |
Growth signals
Latest recorded traffic for Dishi Medical is 170 monthly website visits, up 183.3% over the last three months.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed7 investors entered at this stage
Hillhouse Capital
Linear Capital
FOF Capital- NFNew Silk Road Finance
Infinity Group- OCOvctek China
Fortune Venture
Series A3 investors entered at this stage
Sunland fund
Pan-Lin Asset Management
Hangzhou Capital
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Dishi Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Dishi Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.






